NKTR Nektar Therapeutics
$37.76
Nektar Therapeutics (NKTR) Earnings News
Earnings press releases, previews and reviews for Nektar Therapeutics (NKTR), newest first. Our most recent is preview: Nektar Reports With Shares Halved, Phase 3 Spending Rising and a Jury Trial to Explain.
Wednesday
November 4, 2026
6:10 PM ET
Nektar Reports With Shares Halved, Phase 3 Spending Rising and a Jury Trial to Explain
Earnings Whispers · Preview
Tuesday
October 27, 2026
6:00 PM ET
Nektar Therapeutics to Announce Financial Results for the Third Quarter on Thursday, November 12, 2026, After Close of U.S.-Based Financial Markets
Thursday
August 13, 2026
4:15 PM ET
Nektar Therapeutics Announces Second Quarter 2026 Financial Results
Tuesday
July 28, 2026
6:00 PM ET
Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets
Thursday
May 7, 2026
4:15 PM ET
Nektar Therapeutics Reports First Quarter 2026 Financial Results